company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,446658000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,838255000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9601000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,12512000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1307026000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,62279000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,26102000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,518700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11068000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,30313000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,586183000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,,totalassets,Total Assets,=,debit,usd,1955488000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,32071000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,36989000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,118753000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,74956000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,21543000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,571000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,284883000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,121765000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,28434000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,225575000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,160278000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,38207000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,574259000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,859142000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3786769000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-2689783000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-640000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1096346000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1096346000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1096346000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2009.0,FY,,2009-12-31,2011-02-17 16:37:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1955488000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,243197000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,788214000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12529000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,13099000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1057039000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,72333000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,26102000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,518700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,17182000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,34090000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,596074000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,,totalassets,Total Assets,=,debit,usd,1725446000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,136991000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,35851000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,134414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,74619000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,89446000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,3462000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,474783000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,400000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,24098000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,160049000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,160278000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2265000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,746690000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1221473000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3949449000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3444409000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1067000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,503973000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,503973000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,503973000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,FY,,2010-12-31,2012-02-22 17:08:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1725446000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,569901000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,633110000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4964000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,18464000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1226439000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,65439000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,26102000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,518700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,18059000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,34090000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,596951000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,,totalassets,Total Assets,=,debit,usd,1888829000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,45280000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,24644000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,127969000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,98977000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,14585000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,112000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,311567000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,487225000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,29578000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,177962000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,160278000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,72123000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,927166000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1238733000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3914790000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3264017000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-677000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,650096000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,650096000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,650096000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q3,,2010-09-30,2010-10-28 16:53:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1888829000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,337608000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,641537000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3548000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,21862000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1004555000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,60438000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,26102000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,518700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10317000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,34090000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,589209000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,,totalassets,Total Assets,=,debit,usd,1654202000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,45776000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,46495000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,106668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,78273000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,15164000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,292376000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,86407000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,29701000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,195223000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,160278000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,63082000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,534691000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,827067000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3882753000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3055060000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-558000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,827135000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,827135000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,827135000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q2,,2010-06-30,2010-08-03 16:41:27+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1654202000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,396547000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,696136000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7876000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,26209000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1126768000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,58109000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,26102000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,518700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10310000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,30313000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,585425000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,,totalassets,Total Assets,=,debit,usd,1770302000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,29121000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,92234000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,69575000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,20610000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,211540000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,125316000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,27692000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,215488000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,160278000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,39376000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,568150000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,779690000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3846746000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-2855054000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1080000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,990612000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,990612000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,990612000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2010.0,Q1,,2010-03-31,2010-05-03 16:33:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1770302000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,475320000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,51878000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,493602000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,183135000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,112430000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,14889000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1331254000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,133176000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,30992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,663500000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11268000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,34090000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,739850000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,,totalassets,Total Assets,=,debit,usd,2204280000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,74642000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,243187000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,45037000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,12075000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,17407000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,392348000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,400000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,21381000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,118095000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,243707000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,63237000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,846420000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1238768000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,37036000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4202731000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3414835000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1053000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,786843000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,786843000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,141633000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,928476000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,FY,,2011-12-31,2013-03-01 16:01:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2204280000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,542545000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,50580000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,116140000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,445661000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,67654000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,23245000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1245825000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,101268000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,33501000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,663500000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,13785000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,34119000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,744905000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,,totalassets,Total Assets,=,debit,usd,2091998000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,98416000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,49248000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,229865000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,55695000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,9755000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,99270000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,6700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,548949000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,400000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,21476000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,126221000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,231184000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,33322000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,812203000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1361152000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,36696000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4154171000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3573464000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-945000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,579762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,579762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,114388000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,694150000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q3,,2011-09-30,2011-11-03 17:16:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2091998000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,458195000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,63098000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,135296000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,96016000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,52622000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,21897000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,827124000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,84203000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,33501000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,769300000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14858000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,34114000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,851773000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,,totalassets,Total Assets,=,debit,usd,1763100000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,94664000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,67275000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,141167000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,65018000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,15212000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,92282000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,3350000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,478968000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,400000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,23054000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,134036000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,260448000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,17414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,834952000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1313920000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,36299000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4102830000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3794574000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-707000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,307549000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,307549000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,105332000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,412881000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q2,,2011-06-30,2011-08-09 16:13:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1763100000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,446536000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,376916000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5594000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,17816000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,26112000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,872974000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,70877000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,26102000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,518700000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,15723000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,34111000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,594636000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,,totalassets,Total Assets,=,debit,usd,1538487000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,92100000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,34881000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,116092000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,74193000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,92117000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,6812000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,416195000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,400000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,25926000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,144416000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,160278000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,730620000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1146815000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4012810000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3620505000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-633000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,391672000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,391672000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,391672000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2011.0,Q1,,2011-03-31,2011-05-06 16:18:42+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1538487000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,489407000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,69983000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,831808000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,143250000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,30464000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,24673000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1589585000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,433609000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,30992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,663500000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,9668000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,31934000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,736094000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,,totalassets,Total Assets,=,debit,usd,2759288000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,13707000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,101292000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,264884000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,27566000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,715000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,24460000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,432624000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,400000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,15170000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,18570000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,96242000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,280367000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,281933000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1092282000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1524906000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,38530000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4521597000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3521867000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-550000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,999180000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,999180000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,196672000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1195852000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,FY,,2012-12-31,2014-02-11 16:38:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2759288000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,436886000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,74954000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,861656000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,139629000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,86275000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,35123000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1634523000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,347249000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,30992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,663500000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10393000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,32166000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,737051000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,,totalassets,Total Assets,=,debit,usd,2718823000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,83732000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,273285000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,27303000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,3871000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,18540000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,406731000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,400000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,19559000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,103626000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,279466000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,244695000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1047346000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1454077000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,38299000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4473868000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3445719000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-416000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1027733000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1027733000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,198714000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1226447000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q3,,2012-09-30,2012-11-06 16:32:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2718823000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,454061000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,56024000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,769273000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,185618000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,87805000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,40524000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1593305000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,272561000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,30992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,663500000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10408000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,34090000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,738990000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,,totalassets,Total Assets,=,debit,usd,2604856000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,59352000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,271464000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,27296000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,201000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,18034000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,3363000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,379710000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,400000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,20149000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,110072000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,263017000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,188301000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,981539000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1361249000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,37914000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4426622000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3388176000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-673000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1037773000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1037773000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,167920000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1205693000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q2,,2012-06-30,2012-08-08 16:31:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2604856000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,267923000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,58017000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,712944000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,232228000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,129595000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,35407000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1436114000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,170331000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,30992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,663500000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10816000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,34090000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,739398000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,,totalassets,Total Assets,=,debit,usd,2345843000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,73226000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,241483000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,30491000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,201000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,4701000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,6713000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,356815000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,400000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,20772000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,116189000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,241426000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,105064000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,883451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1240266000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,37496000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4254371000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3323245000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-628000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,930498000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,930498000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,137583000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1068081000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2012.0,Q1,,2012-03-31,2012-05-10 16:17:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2345843000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,569299000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,895777000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,85517000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,14147000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,23836000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1588576000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,696911000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,30992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2562000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,33554000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,,totalassets,Total Assets,=,debit,usd,2319041000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,16893000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,49327000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,271077000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,21510000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,39022000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,397829000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,48754000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,14067000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,49459000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,452527000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,564807000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,962636000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,5323606000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3966895000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-306000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1356405000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1356405000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1356405000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,FY,,2013-12-31,2015-02-13 16:23:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2319041000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,583181000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,51059000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,839469000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,120281000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,13537000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,41104000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1648631000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,648924000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,30992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,250600000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3474000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,127000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,285193000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,,totalassets,Total Assets,=,debit,usd,2582748000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,14429000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,51533000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,280848000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,31007000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,31682000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,409499000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,39381000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,16280000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,77354000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,150203000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,403351000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,686569000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1096068000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,39624000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,5276618000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-4011180000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-550000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1264888000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1264888000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,182168000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1447056000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q3,,2013-09-30,2013-11-07 16:22:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2582748000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,531247000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,58288000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,899449000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,164866000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,19509000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,43231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1716590000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,581738000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,30992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,250600000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4287000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,122000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,286001000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,,totalassets,Total Assets,=,debit,usd,2584329000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,10664000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,48570000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,260849000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,32900000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,28669000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,381652000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,28088000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,17005000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,84066000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,149706000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,375149000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,654014000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1035666000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,39214000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,5210731000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3887048000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1230000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1322453000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1322453000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,186996000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1509449000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q2,,2013-06-30,2013-08-02 16:02:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2584329000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,379099000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,63008000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,860255000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,194054000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,21532000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,47835000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1565783000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,504232000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,30992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,250600000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8693000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,31934000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,322219000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,,totalassets,Total Assets,=,debit,usd,2392234000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,8302000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,59627000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,274061000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,35533000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,30116000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,407639000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,400000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,14755000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,17548000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,90297000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,151664000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,333499000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1007763000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1415402000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,38872000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4577147000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3829883000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1149000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,746115000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,746115000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,191845000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,937960000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2013.0,Q1,,2013-03-31,2013-05-08 16:33:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2392234000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,625259000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,8418000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,761847000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,75964000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,30848000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,44175000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1546511000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,715812000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,39915000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,29000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3265000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,176000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,72356000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,,totalassets,Total Assets,=,debit,usd,2334679000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,32012000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,71194000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,209676000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,17468000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,37904000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,368254000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,280569000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,39293000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,12748000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,27808000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,15044000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,494780000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,870242000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1238496000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,5779539000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-4705450000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,917000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1075006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1075006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,21177000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1096183000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,FY,,2014-12-31,2016-02-16 16:23:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2334679000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,718563000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,759174000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,114308000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,16753000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,41298000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1650096000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,720878000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,30992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3999000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,121000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,35112000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,,totalassets,Total Assets,=,debit,usd,2406086000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,18124000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,38472000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,244279000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,21210000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,50093000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,372178000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,294740000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,42200000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,17218000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,34723000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,489122000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,878003000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1250181000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,5683538000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-4528794000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1161000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1155905000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1155905000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1155905000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q3,,2014-09-30,2014-11-06 16:02:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2406086000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,420558000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,798603000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,81842000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,11982000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,34399000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1347384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,730000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,30992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,9315000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,129000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,40436000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,,totalassets,Total Assets,=,debit,usd,2117820000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,19707000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,55363000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,237789000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,27174000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,22940000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,362973000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,45053000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,10486000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,38105000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,488934000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,582578000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,945551000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,5531026000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-4358734000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-23000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1172269000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1172269000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1172269000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q2,,2014-06-30,2014-07-31 17:08:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2117820000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,424045000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,900155000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,59858000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,11261000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,35011000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1430330000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,726204000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,30992000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,9452000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,130000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,40574000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,,totalassets,Total Assets,=,debit,usd,2197108000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,18323000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,49571000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,234386000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,28836000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,42384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,373500000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,49495000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,13956000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,43889000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,485390000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,592730000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,966230000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,5430527000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-4199352000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-297000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1230878000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1230878000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1230878000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2014.0,Q1,,2014-03-31,2014-05-05 16:07:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2197108000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,714768000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,78910000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,327694000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,173838000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,57207000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,54736000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1407153000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,697715000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,30000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50400000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,284340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6912000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,22083000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,393735000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,,totalassets,Total Assets,=,debit,usd,2498587000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,86841000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,74942000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,305820000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcurrentliabilities,customerdeposits,Customer Deposits,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,16296000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,22268000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,506167000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,223863000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,42923000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,7464000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9714000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,110439000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,504389000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,898792000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1404959000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,6199927000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-5261784000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1824000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,939967000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,939967000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,153661000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1093628000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,FY,,2015-12-31,2017-02-23 15:18:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2498587000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,756250000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,75765000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,249580000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,165272000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,49197000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,63388000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1359452000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,706670000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,284340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11061000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,22086000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,367871000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,,totalassets,Total Assets,=,debit,usd,2433993000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,14153000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,78899000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,249698000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,14000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,18209000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,374959000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,294832000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,39273000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,9122000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,17501000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,113860000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,507714000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,982302000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1357261000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,6108689000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-5188053000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1511000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,922147000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,922147000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,154585000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1076732000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q3,,2015-09-30,2015-10-30 16:23:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2433993000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,870543000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,88318000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,145907000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,94519000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,42113000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,53289000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1294689000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,713378000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,284340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,9136000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,22146000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,366006000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,,totalassets,Total Assets,=,debit,usd,2374073000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,56794000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,72703000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,206030000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,14930000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,23366000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,373823000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,251939000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,42900000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,9677000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,21019000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,112413000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,514086000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,952034000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1325857000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,5989575000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-5092904000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1707000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,894964000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,894964000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,153252000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1048216000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q2,,2015-06-30,2015-08-04 16:16:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2374073000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,664879000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,516255000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,80332000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,34089000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,62648000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1358203000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,708616000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,39915000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,29000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,7952000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,22141000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,99008000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,,totalassets,Total Assets,=,debit,usd,2165827000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,48199000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,43524000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,176981000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,15918000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,17816000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,302438000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,266266000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,46471000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,8355000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,24000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,15093000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,505667000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,865852000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1168290000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,5879723000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-4904056000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,791000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,976458000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,976458000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,21079000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,997537000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2015.0,Q1,,2015-03-31,2015-05-04 16:29:38+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2165827000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1183945000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,47762000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,250612000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,200364000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,77604000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,71253000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1831540000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,698362000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,20276000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,284340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11885000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,366885000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,,totalassets,Total Assets,=,debit,usd,2896787000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,319426000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,61451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,315249000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcurrentliabilities,customerdeposits,Customer Deposits,+,credit,usd,73416000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6005000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,16990000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,792537000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,34976000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,1907000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6632000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,134063000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,588481000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,766059000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1558596000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,6509245000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-5373836000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,21173000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1156582000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1156582000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,181609000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1338191000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,FY,,2016-12-31,2018-02-14 18:01:38+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2896787000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,719692000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,58420000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,408749000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,182229000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,71799000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,61012000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1501901000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,687613000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,53314000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,284340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10002000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,22087000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,420127000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,,totalassets,Total Assets,=,debit,usd,2609641000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,315523000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,50914000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,292015000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9247000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,55142000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,722841000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,31719000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,3314000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6559000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,133270000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,503597000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,678459000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1401300000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,6432172000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-5406781000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3845000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1021546000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1021546000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,186795000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1208341000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q3,,2016-09-30,2016-10-31 16:48:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2609641000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,605866000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,70513000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,465570000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,189356000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,66589000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,56256000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1454150000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,690607000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,33213000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,284340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14203000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,22085000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,404225000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,,totalassets,Total Assets,=,debit,usd,2548982000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,239022000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,51302000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,275165000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,11468000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,45898000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,622855000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,74921000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,34317000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,4801000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7411000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,132810000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,503022000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,757282000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1380137000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,6352684000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-5367940000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3390000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,981354000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,981354000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,187491000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1168845000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q2,,2016-06-30,2016-08-01 16:51:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2548982000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,604245000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,76273000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,421373000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,181878000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,63200000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,55866000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1402835000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,690521000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,30138000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,284340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,7600000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,22088000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,394550000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,,totalassets,Total Assets,=,debit,usd,2487906000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,163543000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,75221000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,272665000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,14705000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,25907000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,552041000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,149571000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,38886000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,6145000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,8490000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,112259000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,504316000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,819667000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1371708000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,6265393000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-5303415000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-4899000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,957079000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,957079000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,159119000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1116198000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2016.0,Q1,,2016-03-31,2016-05-03 17:03:32+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2487906000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1665412000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,423254000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,281343000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,111830000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,167124000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2648963000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,789437000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,29000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,834000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,27396000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,107614000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,,totalassets,Total Assets,=,debit,usd,3546014000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,22531000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,73994000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,443961000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,266774000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,807260000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,20496000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,6341000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,669611000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,696448000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1503708000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,7159874000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-5119723000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-11572000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2028579000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2028579000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,13727000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2042306000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,FY,,2017-12-31,2019-02-13 16:38:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3546014000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1384966000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1803000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,427282000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,263493000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,98192000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,152238000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2327974000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,759978000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,20447000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,29000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10542000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,110373000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,,totalassets,Total Assets,=,debit,usd,3198325000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,19881000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,77138000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,378554000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcurrentliabilities,customerdeposits,Customer Deposits,+,credit,usd,190272000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,13003000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,31891000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,710739000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,20259000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,146000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2917000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,10682000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,650338000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,684342000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1395081000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,7036613000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-5220407000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-25129000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1791077000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1791077000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,12167000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1803244000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q3,,2017-09-30,2017-10-30 17:15:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3198325000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1223130000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,64628000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,445520000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,247949000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,92263000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,107082000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2180572000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,740103000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,20252000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50400000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,284340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,9943000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,364935000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,,totalassets,Total Assets,=,debit,usd,3285594000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,18179000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,75941000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,345062000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcurrentliabilities,customerdeposits,Customer Deposits,+,credit,usd,147686000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,7277000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,31261000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,625406000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,25346000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,527000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4161000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,136649000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,626274000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,792957000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1418363000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,6810481000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-5117455000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-21753000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1671273000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1671273000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,195958000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1867231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q2,,2017-06-30,2017-07-28 16:23:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3285594000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1003679000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,44564000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,405103000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,207955000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,82020000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,128493000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1871814000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,708395000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,20276000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,284340000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11494000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,366494000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,,totalassets,Total Assets,=,debit,usd,2946703000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,19270000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,63145000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,277962000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcurrentliabilities,customerdeposits,Customer Deposits,+,credit,usd,104774000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6057000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,18588000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,489796000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,30355000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,613000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5742000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,135402000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,602002000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,774114000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1263910000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,6619434000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-5135451000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,16025000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1500008000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1500008000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,182785000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1682793000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2017.0,Q1,,2017-03-31,2017-04-28 16:22:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2946703000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,2650134000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,518108000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,409688000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,124360000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,140819000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,3843109000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,812005000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1499672000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,40728000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1590784000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,,totalassets,Total Assets,=,debit,usd,6245898000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,110987000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,958899000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,50406000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1120292000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,581550000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,108853000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,690403000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1810695000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,7424022000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-2989478000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,659000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,4435203000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,4435203000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,4435203000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,FY,,2018-12-31,2020-02-13 16:48:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,6245898000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,2478302000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,8143000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,577583000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,379755000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,124150000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,118678000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,3686611000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,808352000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,29000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,46493000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,125877000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,,totalassets,Total Assets,=,debit,usd,4620840000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,11511000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,92149000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,504240000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,384608000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,992508000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,15141000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,9414000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,669296000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,693851000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1686359000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,7445814000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-4540005000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,307000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2906116000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2906116000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,28365000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2934481000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q3,,2018-09-30,2018-10-25 16:10:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,4620840000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,2145359000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,8510000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,622396000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,393439000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,115025000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,122694000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,3407423000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,815928000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,29000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,32651000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,112035000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,,totalassets,Total Assets,=,debit,usd,4335386000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,15060000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,83034000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,479120000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,350086000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,927300000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,15030000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,9335000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,668838000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,693203000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1620503000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,7359584000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-4668751000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-4605000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2686228000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2686228000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,28655000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2714883000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q2,,2018-06-30,2018-07-26 16:08:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,4335386000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1995893000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,9573000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,481124000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,327294000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,117346000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,109886000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,3041116000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,800670000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,29000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,31804000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,111188000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,,totalassets,Total Assets,=,debit,usd,3952974000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,16919000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,74062000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,411231000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,325100000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,827312000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,16911000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,9636000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,668294000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,694841000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1522153000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,7316910000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-4876111000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-39743000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2401056000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2401056000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,29765000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2430821000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2018.0,Q1,,2018-03-31,2018-04-27 16:36:36+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3952974000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,3109322000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,698972000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,633518000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,167502000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,213515000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,4822829000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,745080000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1002158000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,400000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1190815000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,157583000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2750556000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,,totalassets,Total Assets,=,debit,usd,8318465000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,87610000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1116912000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,130305000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1334827000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,898394000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,898394000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2233221000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,7940195000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1852978000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1973000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,6085244000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,6085244000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,6085244000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,FY,,2019-12-31,2020-05-01 16:37:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,8318465000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,3397941000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,598390000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,443315000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,162306000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,175142000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,4777094000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,733509000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,447525000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1415511000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,140914000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2003950000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,,totalassets,Total Assets,=,debit,usd,7514553000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,92528000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1173783000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,122583000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1388894000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,872265000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,872265000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2261159000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,7670759000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-2436212000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,18847000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,5253394000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,5253394000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,5253394000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q3,,2019-09-30,2019-10-31 16:19:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,7514553000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,3294684000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,656538000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,464900000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,143017000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,151829000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,4710968000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,731131000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1425191000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,115797000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1591372000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,,totalassets,Total Assets,=,debit,usd,7033471000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,77045000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1069072000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,113103000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1259220000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,704286000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,704286000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1963506000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,7566896000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-2493730000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3201000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,5069965000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,5069965000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,5069965000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q2,,2019-06-30,2019-08-01 16:20:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,7033471000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,2893885000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,584150000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,438297000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,136698000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,130009000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,4183039000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,742559000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,50384000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1467518000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,99614000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1617516000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,,totalassets,Total Assets,=,debit,usd,6543114000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,82262000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,532745000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,491461000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1106468000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,713333000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,713333000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1819801000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,7478470000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-2761157000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,6000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,4723313000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,4723313000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,4723313000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2019.0,Q1,,2019-03-31,2019-05-01 16:37:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,6543114000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,3593412000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,596984000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,845269000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,187087000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,223648000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,5446400000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,736303000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1002158000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,400000000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1147705000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,160635000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2710498000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,,totalassets,Total Assets,=,debit,usd,8893201000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,100703000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1258271000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,179776000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1538750000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,892797000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,892797000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2431547000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,7698496000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1250225000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,13383000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,6461654000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,6461654000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,6461654000.0
Vertex Pharmaceuticals Inc,VRTX,54930015RAQRRZ5ZGJ91,0000875320,2020.0,Q1,,2020-03-31,2020-05-01 16:37:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,8893201000.0
